Oncolytics Biotech (ONCY) Common Equity (2009 - 2026)
Oncolytics Biotech's Common Equity came in at -$6.17 million for Q2 2026, compared with $3.7 million a year earlier.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Oncolytics Biotech's Common Equity was -$3.8 million.
- Going back by year, Common Equity was $3.3 million in FY2024 (-83.9%), $20.43 million in FY2023 (+0.2%), $20.38 million in FY2022 (-29.2%) and $28.81 million in FY2021 (+55.9%).
- The Q2 2026 figure represents the lowest quarterly Common Equity in data going back to Q1 2009.
- The fastest year-over-year change in Common Equity over five years came in Q4 2021 (growth of 50.8%), and the weakest in Q3 2025 (a decline of 98.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Oncolytics Biotech | 60.94 Mn | 32.05 Mn | - | -6.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.17 Mn |
| Dec 31, 2025 | -3.80 Mn |
| Sep 30, 2025 | 82,637.50 |
| Jun 30, 2025 | 3.70 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Sep 30, 2024 | 6.70 Mn |
| Jun 30, 2024 | 13.37 Mn |
| Mar 31, 2024 | 16.97 Mn |
| Sep 30, 2023 | 21.51 Mn |
| Jun 30, 2023 | 16.78 Mn |
| Mar 31, 2023 | 19.04 Mn |
| Dec 31, 2022 | 19.56 Mn |
| Sep 30, 2022 | 20.77 Mn |
| Jun 30, 2022 | 23.89 Mn |
| Mar 31, 2022 | 28.05 Mn |
| Dec 31, 2021 | 28.33 Mn |
| Sep 30, 2021 | 33.49 Mn |
| Jun 30, 2021 | 37.50 Mn |
| Mar 31, 2021 | 35.39 Mn |
| Dec 31, 2020 | 19.41 Mn |
API Access
Oncolytics Biotech Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();